Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes

January 20, 2017 updated by: Lawrence Ching Tsen, Brigham and Women's Hospital

The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief.

The secondary objective of this study is to compare the fetal effects of these three epidural labor analgesia techniques.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 1. Nulliparous (first baby) parturient 2. Singleton, vertex gestation at term (37-42 weeks) 3. Less than 5 cm dilation 4. Desires an epidural technique for labor analgesia

Exclusion Criteria:

- 1. Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes) 2. Any contraindication to the administration of an epidural technique 3. History of hypersensitivity or idiosyncratic reaction to local anesthetic or opioid medications 4. Current or historical evidence of a disease which may result in the risk of a cesarean delivery.

5. Evidence of anticipated fetal anomalies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Epidural Technique
Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min
Three different techniques, using the same medications (bupivacaine and fentanyl)
Active Comparator: Combined Spinal Epidural Technique
Bupivacaine 2.5 mg with Fentanyl 25 mcg
Three different techniques, using the same medications (bupivacaine and fentanyl)
Active Comparator: Dural Puncture Epidural Technique
Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min
Three different techniques, using the same medications (bupivacaine and fentanyl)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Outcomes
Time Frame: Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours
Onset, quality, and duration of analgesia, occurrences of hypotension, bradycardia, pruritus, nausea, emesis.
Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fetal Outcomes
Time Frame: Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours
Occurrence of fetal bradycardia or other heart rate changes, changes in fetal heart tracing patterns
Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lawrence C Tsen, MD, Brigham and Women's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2013

Primary Completion (Actual)

January 27, 2016

Study Completion (Actual)

January 27, 2016

Study Registration Dates

First Submitted

November 26, 2013

First Submitted That Met QC Criteria

December 6, 2013

First Posted (Estimate)

December 11, 2013

Study Record Updates

Last Update Posted (Estimate)

January 24, 2017

Last Update Submitted That Met QC Criteria

January 20, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laboring Women Requesting Neuraxial Labor Analgesia

Clinical Trials on Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique

3
Subscribe